Sign in
4

Changes in Ownership

Anebulo Pharmaceuticals, Inc. Filed Acc 0001209191-22-055300

Options or other derivatives

  • Director acquired 59,149 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Calloway Nathaniel Director 2022-11-01 Grant or award · Stock Option (right to buy) +59,149 59,149 D: show line 1 in the form
Loading xslF345X03/doc4.xml…